66 related articles for article (PubMed ID: 34845217)
1. Recurrent de novo pathogenic variant of WASF1 in a Japanese patient with neurodevelopmental disorder with absent language and variable seizures.
Shimojima Yamamoto K; Yanagishita T; Yamamoto H; Miyamoto Y; Nagata M; Ishihara Y; Miyashita Y; Asano Y; Sakata Y; Yamamoto T
Hum Genome Var; 2021 Nov; 8(1):43. PubMed ID: 34845217
[TBL] [Abstract][Full Text] [Related]
2. Trio exome sequencing identified a novel de novo WASF1 missense variant leading to recurrent site substitution in a Chinese patient with developmental delay, microcephaly, and early-onset seizures: A mutational hotspot p.Trp161 and literature review.
Zhao A; Zhou R; Gu Q; Liu M; Zhang B; Huang J; Yang B; Yao R; Wang J; Lv H; Wang J; Shen Y; Wang H; Chen X
Clin Chim Acta; 2021 Dec; 523():10-18. PubMed ID: 34478686
[TBL] [Abstract][Full Text] [Related]
3. The recurrent WASF1 nonsense variant identified in two unaffected Chinese families with neurodevelopmental disorder: case report and review of the literatures.
Tang X; Liu G; Lin L; Xiao N; Chen Y
BMC Med Genomics; 2023 Aug; 16(1):203. PubMed ID: 37641121
[TBL] [Abstract][Full Text] [Related]
4. De Novo Truncating Mutations in WASF1 Cause Intellectual Disability with Seizures.
Ito Y; Carss KJ; Duarte ST; Hartley T; Keren B; Kurian MA; Marey I; Charles P; Mendonça C; Nava C; Pfundt R; Sanchis-Juan A; van Bokhoven H; van Essen A; van Ravenswaaij-Arts C; ; ; Boycott KM; Kernohan KD; Dyack S; Raymond FL
Am J Hum Genet; 2018 Jul; 103(1):144-153. PubMed ID: 29961568
[TBL] [Abstract][Full Text] [Related]
5. Expansion of the Genotypic and Phenotypic Spectrum of WASF1-Related Neurodevelopmental Disorder.
Srivastava S; Macke EL; Swanson LC; Coulter D; Klee EW; Mullegama SV; Xie Y; Lanpher BC; Bedoukian EC; Skraban CM; Villard L; Milh M; Leppert MLO; Cohen JS
Brain Sci; 2021 Jul; 11(7):. PubMed ID: 34356165
[TBL] [Abstract][Full Text] [Related]
6. A recurrent de novo ZSWIM6 variant in a Japanese patient with severe neurodevelopmental delay and frequent vomiting.
Yanagishita T; Eto K; Yamamoto-Shimojima K; Segawa O; Nagata M; Ishihara Y; Miyashita Y; Asano Y; Sakata Y; Nagata S; Yamamoto T
Hum Genome Var; 2021 May; 8(1):16. PubMed ID: 33958584
[TBL] [Abstract][Full Text] [Related]
7. Two different presentations of de novo variants of CSNK2B: two case reports.
Wilke MVMB; Oliveira BM; Pereira A; Doriqui MJR; Kok F; Souza CFM
J Med Case Rep; 2022 Jan; 16(1):4. PubMed ID: 34983633
[TBL] [Abstract][Full Text] [Related]
8. De novo variants in ATXN7L3 lead to developmental delay, hypotonia and distinctive facial features.
Harel T; Spicher C; Scheer E; Buchan JG; Cech J; Folland C; Frey T; Holtz AM; Innes AM; Keren B; Macken WL; Marcelis C; Otten CE; Paolucci SA; Petit F; Pfundt R; Pitceathly RDS; Rauch A; Ravenscroft G; Sanchev R; Steindl K; Tammer F; Tyndall A; Devys D; Vincent SD; Elpeleg O; Tora L
Brain; 2024 May; ():. PubMed ID: 38753057
[TBL] [Abstract][Full Text] [Related]
9. Identification and functional characterization of de novo FOXP1 variants provides novel insights into the etiology of neurodevelopmental disorder.
Sollis E; Graham SA; Vino A; Froehlich H; Vreeburg M; Dimitropoulou D; Gilissen C; Pfundt R; Rappold GA; Brunner HG; Deriziotis P; Fisher SE
Hum Mol Genet; 2016 Feb; 25(3):546-57. PubMed ID: 26647308
[TBL] [Abstract][Full Text] [Related]
10. Neurodevelopmental Disorders Caused by De Novo Variants in KCNB1 Genotypes and Phenotypes.
de Kovel CGF; Syrbe S; Brilstra EH; Verbeek N; Kerr B; Dubbs H; Bayat A; Desai S; Naidu S; Srivastava S; Cagaylan H; Yis U; Saunders C; Rook M; Plugge S; Muhle H; Afawi Z; Klein KM; Jayaraman V; Rajagopalan R; Goldberg E; Marsh E; Kessler S; Bergqvist C; Conlin LK; Krok BL; Thiffault I; Pendziwiat M; Helbig I; Polster T; Borggraefe I; Lemke JR; van den Boogaardt MJ; Møller RS; Koeleman BPC
JAMA Neurol; 2017 Oct; 74(10):1228-1236. PubMed ID: 28806457
[TBL] [Abstract][Full Text] [Related]
11. Expanding the genotype-phenotype correlation of de novo heterozygous missense variants in YWHAG as a cause of developmental and epileptic encephalopathy.
Kanani F; Titheradge H; Cooper N; Elmslie F; Lees MM; Juusola J; Pisani L; McKenna C; Mignot C; Valence S; Keren B; Lachlan K; ; Balasubramanian M
Am J Med Genet A; 2020 Apr; 182(4):713-720. PubMed ID: 31926053
[TBL] [Abstract][Full Text] [Related]
12. Identification of a rare homozygous
Imaizumi T; Kumakura A; Yamamoto-Shimojima K; Ondo Y; Yamamoto T
Intractable Rare Dis Res; 2018 Nov; 7(4):245-250. PubMed ID: 30560016
[TBL] [Abstract][Full Text] [Related]
13. A Japanese adult and two girls with NEDMIAL caused by de novo missense variants in DHX30.
Ueda K; Araki A; Fujita A; Matsumoto N; Uehara T; Suzuki H; Takenouchi T; Kosaki K; Okamoto N
Hum Genome Var; 2021 Jun; 8(1):24. PubMed ID: 34145223
[TBL] [Abstract][Full Text] [Related]
14. Novel de novo variant in
Blackburn PR; Barnett SS; Zimmermann MT; Cousin MA; Kaiwar C; Pinto E Vairo F; Niu Z; Ferber MJ; Urrutia RA; Selcen D; Klee EW; Pichurin PN
Cold Spring Harb Mol Case Stud; 2017 May; 3(3):a001743. PubMed ID: 28487885
[TBL] [Abstract][Full Text] [Related]
15. Identification of an Identical
Jiao X; Morleo M; Nigro V; Torella A; D'Arrigo S; Ciaccio C; Pantaleoni C; Gong P; Grand K; Sanchez-Lara PA; Krier J; Fieg E; Stergachis A; Wang X; Yang Z
Front Pharmacol; 2020; 11():599191. PubMed ID: 33390987
[No Abstract] [Full Text] [Related]
16. De novo missense variants in HECW2 are associated with neurodevelopmental delay and hypotonia.
Berko ER; Cho MT; Eng C; Shao Y; Sweetser DA; Waxler J; Robin NH; Brewer F; Donkervoort S; Mohassel P; Bönnemann CG; Bialer M; Moore C; Wolfe LA; Tifft CJ; Shen Y; Retterer K; Millan F; Chung WK
J Med Genet; 2017 Feb; 54(2):84-86. PubMed ID: 27389779
[TBL] [Abstract][Full Text] [Related]
17. De novo truncating variants in the AHDC1 gene encoding the AT-hook DNA-binding motif-containing protein 1 are associated with intellectual disability and developmental delay.
Yang H; Douglas G; Monaghan KG; Retterer K; Cho MT; Escobar LF; Tucker ME; Stoler J; Rodan LH; Stein D; Marks W; Enns GM; Platt J; Cox R; Wheeler PG; Crain C; Calhoun A; Tryon R; Richard G; Vitazka P; Chung WK
Cold Spring Harb Mol Case Stud; 2015 Oct; 1(1):a000562. PubMed ID: 27148574
[TBL] [Abstract][Full Text] [Related]
18. Expanding the phenotypic spectrum of GABRG2 variants: a recurrent GABRG2 missense variant associated with a severe phenotype.
Zou F; McWalter K; Schmidt L; Decker A; Picker JD; Lincoln S; Sweetser DA; Briere LC; Harini C; ; Marsh E; Medne L; Wang RY; Leydiker K; Mower A; Visser G; Cuppen I; van Gassen KL; van der Smagt J; Yousaf A; Tennison M; Shanmugham A; Butler E; Richard G; McKnight D
J Neurogenet; 2017; 31(1-2):30-36. PubMed ID: 28460589
[TBL] [Abstract][Full Text] [Related]
19. A de novo missense mutation in ZMYND11 is associated with global developmental delay, seizures, and hypotonia.
Moskowitz AM; Belnap N; Siniard AL; Szelinger S; Claasen AM; Richholt RF; De Both M; Corneveaux JJ; Balak C; Piras IS; Russell M; Courtright AL; Rangasamy S; Ramsey K; Craig DW; Narayanan V; Huentelman MJ; Schrauwen I
Cold Spring Harb Mol Case Stud; 2016 Sep; 2(5):a000851. PubMed ID: 27626064
[TBL] [Abstract][Full Text] [Related]
20. A recurrent,
Laboy Cintron D; Muir AM; Scott A; McDonald M; Monaghan KG; Santiago-Sim T; Wentzensen IM; De Luca C; ; Brancati F; Harris DJ; Goueli C; Stottmann R; Prada CE; Biderman Waberski M; Mefford HC
HGG Adv; 2022 Jan; 3(1):100072. PubMed ID: 35047857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
